Sympathetic nerve activity after thoracoscopic cardiac resynchronization therapy in congestive heart failure

Journal of Cardiac Failure

Volumn 11, Issue 7, 2005, Pages 529-533

  Najem, Boutaïna ^a   Preumont, Nicolas ^a   Unger, Philippe ^a   Jansens, Jean Luc ^a   Houssière, Anne ^b   Ciarka, Agnieszka ^a   Stoupel, Eric ^a   Degaute, Jean Paul ^a   Van De Borne, Philippe ^a  

^a ERASME HOSPITAL   (Belgium)

^b UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

Author keywords

Autonomic nervous system; Heart failure; Microneurography; Robotics

Indexed keywords

ANGIOTENSIN ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; SPIRONOLACTONE; STEROID; VASODILATOR AGENT;

ADULT; AGED; ARTICLE; BLOOD PRESSURE MEASUREMENT; CARDIAC RESYNCHRONIZATION THERAPY; CLINICAL ARTICLE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; FEMALE; HEART HEMODYNAMICS; HEART INDEX; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE CONDUCTION DISTURBANCE; HEART RATE; HUMAN; MALE; MAXIMUM PERMISSIBLE DOSE; MUSCLE INNERVATION; PRIORITY JOURNAL; QRS COMPLEX; SYMPATHETIC TONE; THORACOSCOPY; WALKING;

AGED; BLOOD PRESSURE; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; EXERCISE TOLERANCE; FEMALE; HEART CONDUCTION SYSTEM; HEART FAILURE, CONGESTIVE; HEART RATE; HEART VENTRICLES; HUMANS; MALE; MIDDLE AGED; PACEMAKER, ARTIFICIAL; STROKE VOLUME; SYMPATHETIC NERVOUS SYSTEM; THORACOSCOPY; TREATMENT OUTCOME; WALKING;

EID: 25844487701     PISSN: 10719164     EISSN: 15328414     Source Type: Journal    
DOI: 10.1016/j.cardfail.2005.04.001     Document Type: Article

References (35)

1. S. Iuliano, S.G. Fisher, P.E. Karasik, R.D. Fletcher, and S.N. Singh QRS duration and mortality in patients with congestive heart failure Am Heart J 143 2002 1085 1091
2. V. Gottipaty, S. Krelis, F. Lu, E.P. Spencer, V. Shusterman, and R. Weiss The resting electrocardiogram provides a sensitive and inexpensive marker of prognosis in patients with chronic congestive heart failure J Am Coll Cardiol 33 1999 145
3. W.T. Abraham, W.G. Fisher, A.L. Smith, D.B. Delurgio, A.R. Leon, and E. Loh Cardiac resynchronization in chronic heart failure N Engl J Med 346 2002 1845 1853
4. A. Auricchio, C. Stellbrink, S. Sack, M. Block, J. Vogt, and P. Bakker The Pacing Therapies for Congestive Heart Failure (PATH-CHF) study: rationale, design, and endpoints of a prospective randomized multicenter study Am J Cardiol 83 1999 130D 135D
5. A. Auricchio, C. Stellbrink, S. Sack, M. Block, J. Vogt, and P. Bakker Long-term clinical effect of hemodynamically optimized cardiac resynchronization therapy in patients with heart failure and ventricular conduction delay J Am Coll Cardiol 39 2002 2026 2033
6. S. Cazeau, C. Leclercq, T. Lavergne, S. Walker, C. Varma, and C. Linde Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay N Engl J Med 344 2001 873 880
7. L.A. Saxon, T. De Marco, J. Schafer, K. Chatterjee, U.N. Kumar, and E. Foster Effects of long-term biventricular stimulation for resynchronization on echocardiographic measures of remodeling Circulation 105 2002 1304 1310
8. J.B. Young, W.T. Abraham, A.L. Smith, A.R. Leon, R. Lieberman, and B. Wilkoff Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: the MIRACLE ICD Trial JAMA 289 2003 2685 2694
9. C.M. Yu, E. Chau, J.E. Sanderson, K. Fan, M.O. Tang, and W.H. Fung Tissue Doppler echocardiographic evidence of reverse remodeling and improved synchronicity by simultaneously delaying regional contraction after biventricular pacing therapy in heart failure Circulation 105 2002 438 445
10. M.R. Bristow, L.A. Saxon, J. Boehmer, S. Krueger, D.A. Kass, and T. De Marco Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure N Engl J Med 350 2004 2140 2150
11. Cleland JG, Daubert JC, Erdmann E, Freemantle N, Gras D, Kappenberger L, et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med. In press.
12. J.S. Floras Clinical aspects of sympathetic activation and parasympathetic withdrawal in heart failure J Am Coll Cardiol 22 4 Suppl A 1993 72A 84A
13. W.N. Leimbach Jr., B.G. Wallin, R.G. Victor, P.E. Aylward, G. Sundlof, and A.L. Mark Direct evidence from intraneural recordings for increased central sympathetic outflow in patients with heart failure Circulation 73 1986 913 919
14. M.H. Hamdan, J.D. Zagrodzky, J.A. Joglar, C.J. Sheehan, K. Ramaswamy, and J.F. Erdner Biventricular pacing decreases sympathetic activity compared with right ventricular pacing in patients with depressed ejection fraction Circulation 102 2000 1027 1032
15. M.H. Hamdan, S. Barbera, R.C. Kowal, R.L. Page, K. Ramaswamy, and J.A. Joglar Effects of resynchronization therapy on sympathetic activity in patients with depressed ejection fraction and intraventricular conduction delay due to ischemic or idiopathic dilated cardiomyopathy Am J Cardiol 89 2002 1047 1051
16. G. Grassi, A. Vincenti, R. Brambilla, F.Q. Trevano, R. Dell'Oro, and A. Ciro Sustained sympathoinhibitory effects of cardiac resynchronization therapy in severe heart failure Hypertension 44 2004 727 731
17. A. Auricchio, and J.C. Spinelli The promise of resynchronization therapy. Who (and how many) will benefit? Card Electrophysiol Rev 7 2003 17 26
18. C. Alonso, C. Leclercq, F.R. d'Allonnes, D. Pavin, F. Victor, and P. Mabo Six year experience of transvenous left ventricular lead implantation for permanent biventricular pacing in patients with advanced heart failure: technical aspects Heart 86 2001 405 410
19. J.L. Jansens, M. Jottrand, N. Preumont, E. Stoupel, and D. de Canniere Robotic-enhanced biventricular resynchronization: an alternative to endovenous cardiac resynchronization therapy in chronic heart failure Ann Thorac Surg 76 2003 413 417
20. J.J. DeRose, R.C. Ashton, S. Belsley, D.G. Swistel, M. Vloka, and F. Ehlert Robotically assisted left ventricular epicardial lead implantation for biventricular pacing J Am Coll Cardiol 41 2003 1414 1419
21. M.S. Horenstein, H. Walters III, and P.P. Karpawich Chronic performance of steroid-eluting epicardial leads in a growing pediatric population: a 10-year comparison Pacing Clin Electrophysiol 26 2003 1467 1471
22. J.M. Gardin, D.B. Adams, P.S. Douglas, H. Feigenbaum, D.H. Forst, and A.G. Fraser Recommendations for a standardized report for adult transthoracic echocardiography: a report from the American Society of Echocardiography's Nomenclature and Standards Committee and Task Force for a Standardized Echocardiography Report J Am Soc Echocardiogr 15 2002 275 290
23. V. Bittner Six-minute walk test in patients with cardiac dysfunction Cardiologia 42 1997 897 902
24. A. Puglisi, M. Lunati, A.G. Marullo, S. Bianchi, M. Feccia, and F. Sgreccia Limited thoracotomy as a second choice alternative to transvenous implant for cardiac resynchronisation therapy delivery Eur Heart J 25 2004 1063 1069
25. K. Ashino, E. Gotoh, S. Sumita, A. Moriya, and M. Ishii Percutaneous transluminal mitral valvuloplasty normalizes baroreflex sensitivity and sympathetic activity in patients with mitral stenosis Circulation 96 1997 3443 3449
26. D.W. Ferguson, W.J. Berg, J.S. Sanders, P.J. Roach, J.S. Kempf, and M.G. Kienzle Sympathoinhibitory responses to digitalis glycosides in heart failure patients. Direct evidence from sympathetic neural recordings Circulation 80 1989 65 77
27. P. Thoren Role of cardiac vagal C-fibers in cardiovascular control Rev Physiol Biochem Pharmacol 86 1979 1 94
28. A. Al Hesayen, E.R. Azevedo, G.E. Newton, and J.D. Parker The effects of dobutamine on cardiac sympathetic activity in patients with congestive heart failure J Am Coll Cardiol 39 2002 1269 1274
29. S. Velez-Roa, M. Renard, J.P. Degaute, and B.P. van de Peripheral sympathetic control during dobutamine infusion: effects of aging and heart failure J Am Coll Cardiol 42 2003 1605 1610
30. S. Velez-Roa, B.P. van de, and V.K. Somers Dobutamine potentiates the peripheral chemoreflex in patients with congestive heart failure J Card Fail 9 2003 380 383
31. S. Velez-Roa, B. Kojonazarov, A. Ciarka, P. Godart, R. Naeije, and V.K. Somers Dobutamine potentiates arterial chemoreflex sensitivity in healthy normal humans Am J Physiol Heart Circ Physiol 285 2003 H1356 H1361
32. S.A. Hunt, D.W. Baker, M.H. Chin, M.P. Cinquegrani, A.M. Feldmanmd, and G.S. Francis ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: executive summary a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1995 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the International Society for Heart and Lung Transplantation; endorsed by the Heart Failure Society of America Circulation 104 2001 2996 3007
33. M.M. Applefeld, K.A. Newman, F.J. Sutton, W.P. Reed, D.S. Roffman, and B.S. Talesnick Outpatient dobutamine and dopamine infusions in the management of chronic heart failure: clinical experience in 21 patients Am Heart J 114 1987 589 595
34. F. Dies Intermittent dobutamine in ambulatory patients with chronic cardiac failure Br J Clin Pract 45 1986 37 44
35. C.F. Notarius, S. Ando, G.A. Rongen, and J.S. Floras Resting muscle sympathetic nerve activity and peak oxygen uptake in heart failure and normal subjects Eur Heart J 20 1999 880 887